Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa Licitra

Showing results (61-70 of 311) with videos related to

Pageof 32
Sort By:
Frontiers in Oncology|September 10, 2019
The Evolving Role of Taxanes in Combination With Cetuximab for the Treatment of Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck: Evidence, Advantages, and Future DirectionsJoël Guigay, Makoto Tahara, Lisa Licitra, et al.
Critical Reviews in Oncology/Hematology|November 27, 2009
Major and minor salivary gland tumorsMarco Guzzo, Laura D Locati, Franz J Prott, et al.
Oral Oncology|March 26, 2017
Lung metastasectomy in adenoid cystic cancer: Is it worth it?Lara Girelli, Laura Locati, Carlotta Galeone, et al.
Clinical Therapeutics|October 22, 2019
Cost-effectiveness of Molecular Profile Patient Selection for First-line Treatment of Recurrent/Metastatic Head and Neck CancerCarla Rognoni, Silvana Quaglini, Jan Baptist Vermorken, et al.
Head & Neck|October 9, 2012
Safety and feasibility of every-other-week maintenance cetuximab after first-line chemotherapy in patients with recurrent or metastatic head and neck squamous cell cancerPaolo Bossi, Gabriela Kornek, Gaetano Lanzetta, et al.
European Journal of Cancer (Oxford, England : 1990)|October 1, 2015
Prognoses and improvement for head and neck cancers diagnosed in Europe in early 2000s: The EUROCARE-5 population-based studyGemma Gatta, Laura Botta, María José Sánchez, et al.
Critical Reviews in Oncology/Hematology|February 27, 2003
Major and minor salivary glands tumoursLisa Licitra, Cesare Grandi, Franz J Prott, et al.
Critical Reviews in Oncology/Hematology|July 6, 2002
Cancer of the anal regionLisa Licitra, Silvia Spinazzé, Roberto Doci, et al.
Expert Opinion on Therapeutic Targets|March 7, 2013
RET inhibition: implications in cancer therapyMaria Grazia Borrello, Elena Ardini, Laura D Locati, et al.
Cancers of the Head & Neck|January 29, 2020
Transcriptomics and Epigenomics in head and neck cancer: available repositories and molecular signaturesMara S Serafini, Laura Lopez-Perez, Giuseppe Fico, et al.
Pageof 32

Showing results (61-70 of 311) with videos related to

Sort By:
Pageof 32
Frontiers in Oncology|September 10, 2019
The Evolving Role of Taxanes in Combination With Cetuximab for the Treatment of Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck: Evidence, Advantages, and Future DirectionsJoël Guigay, Makoto Tahara, Lisa Licitra, et al.
Critical Reviews in Oncology/Hematology|November 27, 2009
Major and minor salivary gland tumorsMarco Guzzo, Laura D Locati, Franz J Prott, et al.
Oral Oncology|March 26, 2017
Lung metastasectomy in adenoid cystic cancer: Is it worth it?Lara Girelli, Laura Locati, Carlotta Galeone, et al.
Clinical Therapeutics|October 22, 2019
Cost-effectiveness of Molecular Profile Patient Selection for First-line Treatment of Recurrent/Metastatic Head and Neck CancerCarla Rognoni, Silvana Quaglini, Jan Baptist Vermorken, et al.
Head & Neck|October 9, 2012
Safety and feasibility of every-other-week maintenance cetuximab after first-line chemotherapy in patients with recurrent or metastatic head and neck squamous cell cancerPaolo Bossi, Gabriela Kornek, Gaetano Lanzetta, et al.
European Journal of Cancer (Oxford, England : 1990)|October 1, 2015
Prognoses and improvement for head and neck cancers diagnosed in Europe in early 2000s: The EUROCARE-5 population-based studyGemma Gatta, Laura Botta, María José Sánchez, et al.
Critical Reviews in Oncology/Hematology|February 27, 2003
Major and minor salivary glands tumoursLisa Licitra, Cesare Grandi, Franz J Prott, et al.
Critical Reviews in Oncology/Hematology|July 6, 2002
Cancer of the anal regionLisa Licitra, Silvia Spinazzé, Roberto Doci, et al.
Expert Opinion on Therapeutic Targets|March 7, 2013
RET inhibition: implications in cancer therapyMaria Grazia Borrello, Elena Ardini, Laura D Locati, et al.
Cancers of the Head & Neck|January 29, 2020
Transcriptomics and Epigenomics in head and neck cancer: available repositories and molecular signaturesMara S Serafini, Laura Lopez-Perez, Giuseppe Fico, et al.
Pageof 32